What's New in Acne 2024

The presentation discusses advancements in acne treatment for 2024, covering new medications, devices, and concepts. Notable medications include a combination of benzoyl peroxide and tretinoin, which uses microencapsulation to reduce irritation while delivering effective treatment. Another significant addition is Clascoterone, an androgen receptor inhibitor that addresses acne at the sebaceous gland level, ensuring safety for male patients. A newly launched topical triple combination drug—Clindamycin, adapalene, and benzoyl peroxide—demonstrates increased efficacy compared to traditional treatments. Laser treatment using a neodymium YAG laser shows promise in selectively targeting sebaceous glands with minimal side effects, particularly in darker-skinned individuals. Changes in FDA regulations for acne medications are expected to improve access and streamline processes. The psychological impact of acne on patients is emphasized through a study documenting societal biases against those with severe acne. Future developments mentioned include a potential acne vaccine targeting the virulence factors of C. acnes without destroying beneficial skin bacteria. This vaccine approach aims to provide therapeutic benefits for patients with moderate acne rather than preventive measures.